Abdominal and back pain in a 65-year-old patient with metastatic prostate cancer

2009 Brawley, 2009, Screening for prostate cancer, CA Cancer J Clin, 59, 264, 10.3322/caac.20026 Lim, 2008, Screening for prostate cancer in U.S. men: ACPM position statement on preventive practice, Am J Prev Med, 34, 164, 10.1016/j.amepre.2007.10.003 U.S. Preventive Services Task Force, 2008, Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement, Ann Intern Med, 149, 185, 10.7326/0003-4819-149-3-200808050-00008 Smith, 2008, Cancer screening in the United States, 2008: a review of current American Cancer Society guidelines and cancer screening issues, CA Cancer J Clin, 58, 161, 10.3322/CA.2007.0017 Grönberg, 2003, Prostate cancer epidemiology, Lancet, 361, 859, 10.1016/S0140-6736(03)12713-4 Strief, 2008, An overview of prostate cancer: diagnosis and treatment, Medsurg Nurs, 17, 258 Lishchyna, 2004, Acute onset-low back pain and hip pain secondary to metastatic prostate cancer: a case report, J Can Chiropr Assoc, 48, 5 Hamilton, 2006, Clinical features of prostate cancer before diagnosis: a population-based, case-control study, Br J Gen Pract, 56, 756 Sarma, 2006, Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men, J Urol, 176, 1108, 10.1016/j.juro.2006.04.075 Thompson, 2007, Prostate-specific antigen in the early detection of prostate cancer, CMAJ, 176, 1853, 10.1503/cmaj.060955 Rosser, 2008, Prostate cancer—to screen, or not to screen, is that the question?, BMC Urol, 8, 20, 10.1186/1471-2490-8-20 Andriole, 2009, PLCO Project Team. Mortality results from a randomized prostate-cancer screening trial, N Engl J Med, 360, 1310, 10.1056/NEJMoa0810696 Fritz, 2009, Screening and prostate-cancer mortality in a randomized European study, N Engl J Med, 360, 1320, 10.1056/NEJMoa0810084 Ketchandji, 2009, Cause of death in older men after the diagnosis of prostate cancer, J Am Geriatr Soc, 57, 24, 10.1111/j.1532-5415.2008.02091.x Lage, 2008, The cost of treating skeletal-related events in patients with prostate cancer, Am J Manag Care, 14, 317 Canby-Hagino, 2007, Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL, Urol, 70, 748, 10.1016/j.urology.2007.06.1105 Thompson, 2004, Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter, N Engl J Med, 350, 2239, 10.1056/NEJMoa031918 Quinlan, 2007, Is digital rectal examination still necessary in the early detection of prostate cancer?, Ir J Med Sci, 176, 161, 10.1007/s11845-007-0018-x Galic, 2003, Comparison of digital rectal examination and prostate specific antigen in early detection of prostate cancer, Coll Antropol, 27, 61 Fowler, 2002, Prospective study of cancer detection in black and white men with normal digital rectal examination but prostate specific antigen equal or greater than 4.0 ng/mL, Cancer, 94, 1661, 10.1002/cncr.10446 LaSpina, 2008, Update on the diagnosis and management of prostate cancer, Can J Urol, 15, 3 Wiebe, 2008, Outcome analysis of prostate cancer patients with pre-treatment PSA greater than 50 ng/ml, Can J Urol, 15, 4078 Gerstenbluth, 2002, The accuracy of the increased prostate specific antigen level (greater than or equal to 20 ng./ml.) in predicting prostate cancer: is biopsy always required?, J Urol, 168, 1990, 10.1016/S0022-5347(05)64279-6